
分组1 - Hyperfine, Inc. reported a quarterly loss of $0.12 per share, consistent with the Zacks Consensus Estimate, compared to a loss of $0.14 per share a year ago [1] - The company posted revenues of $2.7 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 7.03%, and down from $3.63 million year-over-year [2] - Hyperfine shares have increased approximately 36.4% since the beginning of the year, outperforming the S&P 500's gain of 9.6% [3] 分组2 - The earnings outlook for Hyperfine is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The estimate revisions trend for Hyperfine was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] - The current consensus EPS estimate for the upcoming quarter is -$0.11 on revenues of $3.87 million, and -$0.49 on revenues of $13.48 million for the current fiscal year [7] 分组3 - The Medical - Instruments industry, to which Hyperfine belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, which may impact stock performance [8]